M&A Snapshot: scPharmaceuticals rises on $360M acquisition deal by MannKind
Published 2 months ago
Aug 25, 2025 at 12:09 PM
Positive
Auto
[ ]
Seeking Alpha
MORE ON MANNKIND, SCPHARMACEUTICALS
* scPharmaceuticals Inc. (SCPH) Q2 2025 Earnings Call Transcript [https://seekingalpha.com/article/4811332-scpharmaceuticals-inc-scph-q2-2025-earnings-call-transcript]
* MannKind Corporation (MNKD) Q2 2025 Earnings Conference Call Transcript [https://seekingalpha.com/article/4809779-mannkind-corporation-mnkd-q2-2025-earnings-conference-call-transcript]
* MannKind Corporation: A Post-Q2 Assessment [https://seekingalpha.com/article/4809712-mannkind-corporation-post-q2-assessment]
* ScPharmaceuticals anticipates meaningful Q3 nephrology contribution as FUROSCIX shipments rise 45% in Q2 2025 [https://seekingalpha.com/news/4482806-scpharmaceuticals-anticipates-meaningful-q3-nephrology-contribution-as-furoscix-shipments]
* MannKind outlines $500M Blackstone financing while advancing Afrezza pediatric launch and IPF pipeline [https://seekingalpha.com/news/4480643-mannkind-outlines-500m-blackstone-financing-while-advancing-afrezza-pediatric-launch-and-ipf]